OBJECTIVES: Video-assisted thoracoscopic anatomical resections are increasingly used in Europe to manage primary lung cancer. The purpose of this study was to compare the outcome following thoracoscopic versus open lobectomy in case-matched groups of patients from the European Society of Thoracic Surgeon (ESTS) database.
INTRODUCTION
Video-assisted thoracoscopic anatomical resections are increasingly used in Europe to manage primary lung cancer. As experiences grow, the variety of procedures that can be performed using this minimally invasive approach is expanding and consequently revolutionized our discipline. The debate concerning long-term survival seems to be now outdated, as the thoracoscopic approach to lobectomy for non small-cell lung cancer (NSCLC) does not result in worse long-term survival compared with thoracotomy [1] . Proponents of video-assisted thoracoscopic approach have emphasized several potential advantages compared with thoracotomy. The concept that lobectomy via thoracoscopy [video-assisted thoracoscopic surgery (VATS)-L] may have a lower complication profile has been recently analysed in series including patients having VATS-L and lobectomy via thoracotomy (TH-L). Three main robust studies-one systematic review [2] , one meta-analysis [3] and one propensity-matched from the Society of Thoracic Surgeons (STSs) database [4] -concluded that video-assisted thoracoscopic procedures had significantly less morbidity (overall and specific) and a shorter hospital stay than open procedures. In addition, recent guidelines emanating from the American College of Chest Physician (ACCP) promote the use of video-assisted thoracoscopic procedure over thoracotomy for patients with stage I NSCLC for anatomical pulmonary resection in experienced centres [5] .
We queried the European Society of Thoracic Surgeons (ESTS) database to perform a survey on VATS practice within Europe. The aim of the current study was thus to compare the outcome following thoracoscopic versus open lobectomy in case-matched groups of patients from the ESTS database.
MATERIAL AND METHODS

Data source
The ESTS launched its own database in an Internet version on 1 January 2007. At the time of the latest report, there were 235 participating sites within Europe (departments or individual surgeons). Harvested data were analysed on a standardized data form that includes information about patient baseline demographics, medical history and comorbidities, preoperative assessment, surgical procedures, cancer staging and outcomes. The software includes functions that allow participating surgeons to benchmark their activity against national averages. Regular, external, onsite audits, initiated in 2010, are carried out to verify the accuracy of data collection [6] . The database characteristics, collection and maintenance have been previously described in detail [7] [8] [9] .
Patient population
The study population consists in patients having lobectomy for primary lung cancer, as the primary procedure, at ESTS participating hospitals between 1 January 2007 and 31 December 2013. VATS lobectomy was defined as the use of a 3-6 cm access incision without rib-spreading, one to three additional 1 cm ports, and the use of a thoracoscope to visualize the dissection and subsequent lobectomy. All data were collected, using the ESTS data collection platforms. Only patients submitted from units contributing at least 100 consecutive lung resections (comprising 85% of the total dataset) were included and used for analysis. The exclusion criteria were the following: prior thoracic surgery, pulmonary procedure other than lobectomy, approach other than thoracoscopy or thoracotomy and finally if both thoracoscopy and thoracotomy were listed as the approach. Twenty-eight thousand seven hundred and seventy-one patients were identified (26 050 having thoracotomy, 2721 having thoracoscopy). The distribution of techniques used for lobectomies performed during the study period is shown in Fig. 1 .
Definition of complications
Risk factors and outcomes were defined and standardized at database outset. Definitions can be found in the recently published paper by a collaborative task force of the STS and ESTS [10] .
Data collection
Data collection for each patient included continuous variables [age at the time of surgery with missing values (0.4%) entered according to median values, body mass index with missing values (7.2%) entered by gender-specific median values, predictive postoperative forced expiratory volume in 1 s ( ppoFEV1) as a percent of predicted with missing values (25.4% missing) entered according to median values]; binary variables (0% missing) with all missing value defaulted to 'no' per the ESTS database before the procedure (clinical status at the time of surgery, coronary artery disease, any previous cardiac surgery, hypertension, arrhythmia, cardiac failure, diabetes, serum creatinine >2 mg/dl, cerebrovascular history, preoperative chemotherapy); and categorical variables [lobectomy procedure site (1.0% missing), American Society of Anesthesiologists Risk Scale (1.3% missing), Eastern Cooperative Oncology Group (ECOG) score (6.9% missing), Medical Research Council dyspnoea score (15.2% missing), for which a new missing-data indicator category was retained for the three last variables]. Pathological staging in accordance with the American Joint Committee on Cancer (I-III) was also reported.
Statistical analysis
Propensity scores were estimated, using a logistic regression model including the following variables: age, gender, ECOG score, American Society of Anesthesiologists (ASA) risk scale, body mass index (BMI), morphology, coronary artery disease, cardiac failure, diabetes, preoperative chemotherapy or radiotherapy, cerebrovascular disease, Medical Research Council dyspnoea score. Patients were then matched using a Greedy 5-1 digit-matching algorithm [11] . Standardized difference (%) was used to assess significance in differences of preoperative variables as well as pathological staging between the two groups (>10 and <−10 being inadequately balanced). Standardized difference was used rather than P-value to establish whether adequate balance was achieved in matching, and hence better for propensity matching [12] . Postoperative outcomes analysed for each group were compared using McNemar's tests for qualitative variables, and Student's paired t-tests for quantitative variables. Subgroup analyses were undertaken on the following categories of patients: aged 70 years and over, ASA >2, BMI < 18.5, ppoFEV1% < 40%. All other statistical analyses were performed with the SAS 9.3 software (SAS Institute, Inc., Cary, NC, USA).
RESULTS
After exclusions, 28 771 patients were identified: 26 050 having thoracotomy and 2721 having thoracoscopy. Propensity score yielded two well-matched groups of 2721 patients.
Matching based on propensity scores produced 2721 patients in each group for analysis of preoperative outcomes. The baseline patients' characteristics of these 2721 patients-derived from an initial cohort of 28 771 patients-are given in Table 1 .
Analysis of the propensity-matched groups for postoperative outcomes demonstrated that VATS-L was associated with a significantly lower morbidity than TH-L: 792 patients (29.1%) of patients who had a thoracoscopic lobectomy had complications, compared with 863 patients (31.7%) of those who had lobectomy by thoracotomy (P = 0.0357). Mortality at hospital discharge was significantly lower in the VATS-L group [n = 27 (1.0%) vs 50 (1.9%), P = 0.002], as given in Table 2 .
Specific postoperative complications included in the ESTS database were also compared in the two matched groups (Table 2) . Compared with TH-L, VATS-L was associated with a lower incidence of major cardiopulmonary complications [n = 316 (15.9%) vs 435 (19.6%), P = 0.0094], atelectasis requiring bronchoscopy [n = 65 (2.4%) vs 150 (5.5%), P < 0.0001], initial ventilation >48 h [n = 18 (0.7%) vs 38 (1.4%), P = 0.0075] and wound infection [n = 6 (0.2%) vs 17 (0.6%), P = 0.0218]. There was no difference in the incidence of postoperative atrial fibrillation between the two groups (P = 0.14). The rate of unexpected admission to intensive care unit (ICU) was significantly greater in the VATS-L group (1.3 vs 0.6%, P = 0.0047). Length of stay was also shorter by a mean of 2 days for those having VATS-L (mean: 7.8 days vs 9.8 days, P = 0.0003).
When analysing specifically patients older than 70 years (n = 1601 patients), the results showed that the VATS-L group (n = 789 patients) had significantly less 'overall' complications (32.8 vs 38.5%, P < 0.0001) and major cardiopulmonary complications (13.4 vs 20.2%, P < 0.0001), a lower incidence of postoperative atrial fibrillation (5.7 vs 8.7%, P < 0.0001) and atelectasis requiring bronchoscopy (1.9 vs 6.5%, P = 0.0013) when compared with the TH-L group (n = 812 patients). Mortality at hospital discharge was reduced by one-third in the VATS-L group (1.9 vs 2.9%, P = 0.0011), and length of stay was shorter by a median of 1 day (median: 7 days vs 8 days, P < 0.0001).
For ASA >2 patients (n = 1099 patients), the VATS-L group (n = 556 patients) provided significantly less 'overall' complications (38.5 vs 42.0%, P = 0.0024), less major cardiopulmonary complications (18.0 vs 23.0%, P < 0.0001), less atelectasis requiring bronchoscopy (4.1 vs 7.9%, P = 0.0032), less pneumonia (9.3 vs 10.5%, P = 0.0024), a shorter length of stay (median: 7 days vs 9 days, P < 0.0001) and a lower mortality at hospital discharge (2.1 vs 3.9%, P = 0.0011) when compared with the TH-L group (n = 543 patients).
Interestingly, within the subgroup of 217 patients with a low BMI (<18.5), the VATS-L group (n = 103 patients) had significantly less atelectasis requiring bronchoscopy (1.9 vs 10.5%, P = 0.0201), a reduced length of stay (median: 7 days vs 8 days, P = 0.0008), and a 5-fold lower mortality rate at hospital discharge (1.0 vs 5.2%, P = 0.041) when compared with the TH-L group (n = 114 patients).
Concerning the sub-group of 100 patients with ppoFEV1% < 40%, there were less major cardiopulmonary complications (12.7 vs 31%, P = 0.0247) as well as a shorter length of stay (median 7 days vs 11.5 days, P = 0.0214) in the VATS-L group (n = 55 patients) when compared with the TH-L group (n = 45 patients). There was no significant difference in mortality rate at hospital discharge between the two groups. A trend was observed concerning the rate of atelectasis requiring bronchoscopy (1.8 vs 11.1%, P = 0.0875) and the rate of postoperative atrial fibrillation (0 vs 6.7%, P = 0.0878) in favour of the VATS-L group.
Postoperative outcomes as well as clinical and pathological staging of the unmatched cohort of 28 771 patients can be found in Tables 3 and 4 for comparisons.
DISCUSSION
Background and objective
Several studies have shown that VATS lobectomy is superior to open approach in terms of early outcomes (i.e. complications and hospital stay). Most of these studies have included patients from single centres or North American organizational databases. No information exists in the literature regarding the outcome of VATS lobectomy in a large organizational database in Europe, which may reflect the current practice in this Continent. Therefore, the objective of this study was to query the ESTS database regarding the early outcomes (complication rates, mortality at hospital discharge and length of stay) of VATS lobectomy compared with open lobectomy.
European Society of Thoracic Surgeon database
The ESTS database is a web-based general thoracic surgery database, which is voluntary and free to all ESTS members. Information on all general thoracic procedures are collected with a special emphasis to lung resection, which is the most common and representative operation in our specialty. In the last edition of the ESTS Database Annual Report [13] , a total of 29 234 lobectomies (all diagnoses) were included from 2007 to 2014. This population represented the base of the present analysis. Along with several baseline and procedural characteristics of the patients, the database collects well-defined complications [10] .
Main findings
In the present study, we showed that patients operated on through VATS developed a significantly lower rate of total complications and cardiopulmonary complications according to the ESTS definition. Of note, we found that mortality at hospital discharge, which is the easiest and most reliable measure of mortality we can glean from the ESTS database, in VATS patients was almost half of that observed in open cases, a finding that has not been universally demonstrated so far in the literature. However, cautious interpretation of this result is needed as there are missing data for the variable 'death' (8.4%). The positive influence of VATS was particularly evident in highrisk patients. In particular, we showed that VATS lobectomy was protective in elderly patients (older than 70 years) when compared with thoracotomy, confirming similar findings from a single-centre US report [14] or from Japan [15] . In addition, the results we found concerning low BMI patients are also in line with the recent findings by Thomas et al. [16] , derived from the French Epithor database, who advocate a special attention in this particular subgroup with aggressive prophylactic therapy in the perioperative period and specific intraoperative actions to prevent prolonged air leaks and bronchial stump dehiscence. Importantly, in patients with a prohibitive predicted postoperative FEV1 < 40%, our results also clearly promote VATS lobectomy. This is in line with recent evidence published from the STS database in the USA [17] , confirming a similar positive trend in Europe.
Although the ESTS database includes patients from several countries with different health care systems and reimbursement policies, the positive association between VATS lobectomy and reduction in hospital stay appears consistent with the data from US centres and databases [18, 19] , representing a more uniform health care system. Although in Europe most countries used a DRG financial system, which prevents the immediate translation of shortened hospital stay into reduced expenditures and increased revenues, the benefits of a shortened hospital stay are not merely economic. Short hospital stay allows for indirect benefit including internal staffing rationing during weekend, cycling more patients for operation, meeting cancer targets, and improving patient experience with care.
Limitations
All analyses of databases need to be interpreted with the knowledge of their inherent strengths and weaknesses.
Although propensity matching reduces the bias inherent in a comparison of two surgical techniques, it is not equivalent to a prospective randomized trial. The significant upstaging in open lobectomies when compared with VATS in our study most probably reflects a selection bias-surgeons tend to include more patients with early stages NSCLC for VATS, particularly in the early phase of the VATS experience [20] . The analysis was performed in a large multicentre organizational database and as such it relies on the accuracy of the submitted data from the individual participating units. Information to this type of procedure is lacking due to the generic nature of the database, which was not designed specifically for this analysis. For instance, the information regarding the rate of conversion and whether converted cases were classed as VATS was not present. Future specific databases, such as a devoted 'VATS page', are under development within ESTS database committee for a more accurate analysis of this procedure.
The recording of complications in large multicentre databases represents a critical aspect. Although complications were strictly defined at the outset of the database and definitions are clearly published in the Annual Report, problems of under-reporting or miscoding can still happen, when complications are imputed by multiple end-users. In addition, although 50 variables are mandatory, we acknowledge some missing data in the ESTS database, particularly for stage III and ppoFEV1%. Only a small proportion of data of those units participating to the Institutional Accreditation Program are checked for quality and consistency with data source. However, the majority of data were not centrally audited and this needs to be taken into account when interpreting results from organizational databases of this scale. As the ESTS database is not designed for the follow-up analyses and Europe lacks a centralized social health care system for recording deaths after treatment, data regarding long-term survival after VATS or thoracotomy were not available. No information is available in the database regarding experience of individual centres in performing VATS lobectomies (i.e. institutional or individual surgeon volumes). As volume may likely influence learning curve, this information would be of interest in future refinements of this analysis for a more in depth interpretation of the results [21] .
CONCLUSIONS
Data from the ESTS database confirmed that lobectomy performed through VATS is associated with a lower incidence of complications and mortality compared with thoracotomy. These data represent a solid benchmark for reflecting European practice and may warrant a more widespread adoption of this technique on this continent. 
